Bio-Rad Laboratories Class BBIO.B
13F holders, Q1 2026 (March 31)7holders +1
1new positions
0sold out
$278.07avg. 13F price*
At the end of Q1 2026, 7 institutions reported holding Bio-Rad Laboratories Class B (BIO.B) in their 13F filings, up 1 from Q4 2025. 1 opened new positions and 0 sold out. The largest holders were Flow Traders U.S. LLC ($274K), CSS LLC ($272K) and Focus Partners Wealth ($211K).
- Company
- Bio-Rad Laboratories Class B
- CUSIP
- 090572108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $274K |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 1,005 shares bought and 61 shares sold, net +944 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Flow Traders U.S. LLC | 0.01% | New | 985 | $274K |
| CSS LLC | 0.04% | Reduce -5.9% | 977 | $272K |
| Focus Partners Wealth | 0.00% | No change | 760 | $211K |
| Morgan Stanley | 0.00% | Add +2.1% | 712 | $198K |
| Wells Fargo & Company | 0.00% | No change | 170 | $47K |
| Whittier Trust Co. | 0.00% | No change | 160 | $44K |
| UBS Group AG | 0.00% | Add +62.5% | 13 | $4K |
"% of holder's portfolio" is BIO.B's weight in each manager's 13F, not the share of Bio-Rad Laboratories Class B the manager owns.